Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05504070 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Venclose digiRF System Post Market Study

StatusActive, Not Recruiting
PhaseNot applicable
SponsorC. R. Bard
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Primary completion date: Jul 9, 2025 to Jul 17, 2025
    v11
  2. Study sites: 3 to 7v10
  3. Primary completion date changed from estimate of Jun 2025 to Jul 9, 2025v9
  4. Primary completion date: Apr 2025 to Jun 2025v8
  5. Primary completion date: Jan 2025 to Apr 2025v7
Show 5 earlier versionsHide 5 earlier versions
  1. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 3
    • Start date changed from estimate of Oct 2023 to Sep 8, 2023
    v6
  2. Start date: Jul 2023 to Oct 2023v5
  3. Start date: Apr 2023 to Jul 2023v4
  4. Start date: Jan 2023 to Apr 2023v3
  5. Start date: Sep 2022 to Jan 2023
    • Primary completion date: Oct 2025 to Jan 2025
    • Interventions: Venclose digiRF System (Device) to Venclose MAVEN System (digiRF generator w MAVEN catheter) (Device), Venclose System (digiRF generator w EVSRF catheter) (Device)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
C. R. Bard
11 trials monitored
See 2 trials at risk
A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins.
Trial Details
NCT Number NCT05504070
Lead Sponsor C. R. Bard
Conditions
(from sponsor)		 Venous Reflux, Chronic Venous Insufficiency
Enrollment 203 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov